Stock Analysis
Data Source: SEC EDGAR 13F
Updated Hourly

Sagimet Biosciences Inc (SGMT)

86 + Investors. Track Smart Money conviction in SGMT. See who's accumulating, reducing, or initiating positions.

Current Price
-- USD
Analyst Target
-- (0 analysts)
Upside
0.00%
Net Flow Q/Q
→ 0
Streak
1Q —
Buyers last Q
60%

Smart Money Signals — SGMT

Based on 86 hedge funds · latest filing: 2026 Q1 · updated quarterly

➡️

No change last quarter

last 6Q
The number of hedge funds holding this stock didn't change last quarter. Neither a buying nor selling signal on its own — watch the next quarter for direction.
🏔️

At the ownership peak (100% of max)

100% of all-time peak
86 hedge funds hold SGMT right now — the highest count in 3.0 years. When ownership is this concentrated, any bad news can trigger a chain reaction: one big fund sells, others follow. This is a classic 'crowded trade' — high popularity doesn't equal safety.
🚀

Fast accumulation — +25% more funds vs a year ago

fund count last 6Q
+17 new funds entered over the past year (+25% YoY). That's a rapid rush of institutional money. Fast accumulation often signals a major thesis — but it also means the stock could fall quickly if that thesis breaks.
🟢

More buyers than sellers — 60% buying

50 buying34 selling
Last quarter: 50 funds were net buyers (16 opened a brand new position + 34 added to an existing one). Only 34 were sellers (18 trimmed + 16 sold completely). A clear majority buying is a strong confirmation signal.
⚠️

Fewer new buyers each quarter (-11 vs last Q)

new funds entering per quarter
Funds opening this position for the first time: 23 → 21 → 27 → 16. Each quarter fewer new institutions are entering. This usually means most funds that wanted in are already in — the stock is well-known but the pool of potential new buyers is shrinking.
📌

Mixed — 29% long-term, 36% new

■ 29% conviction (2yr+) ■ 35% medium ■ 36% new
Of the 86 current holders: 25 (29%) held >2 years, 30 held 1–2 years, and 31 entered in the last year. A mixed base — the stock has long-term believers but also recent buyers who haven't been tested by a downturn yet.
➡️

Steady discovery — ~16 new funds/quarter

18 → 23 → 21 → 27 → 16 new funds/Q
New funds entering each quarter: 23 → 21 → 27 → 16. Consistent flow of new institutional buyers without clear acceleration or slowdown.
📊

Mixed cohorts — 37% veterans, 35% new entrants

■ 37% veterans ■ 27% 1-2yr ■ 35% new
Of 91 current holders: 34 (37%) held 2+ years, 25 held 1–2 years, 32 (35%) entered in the past year. Balanced distribution — some institutional memory, some recent momentum buyers.
✅

Strong quality — 23% AUM from major funds

23% from top-100 AUM funds
26 of 86 holders rank in the top 100 by AUM, accounting for 23% of total institutional value held. A meaningful share of the ownership value comes from the most well-resourced institutions.
4.4
out of 10
Moderate Exit Risk
Exit risk score 4.4/10 — some crowding factors present, but no critical concentration. Watch ownership trend over the next 1–2 quarters for direction.

Methodology note: these Smart Money cards use consecutive 13F disclosure snapshots, not trade-by-trade execution data. "Buying", "selling", "new holders", and "trimmed" refer to quarter-over-quarter changes in reported holders, aggregate shares, or disclosed position values between filings. They are useful for ownership regime analysis and crowding, but they do not imply exact trade timing on the filing date.

Institutional Sentiment Summary — SGMT

In 2026 Q1, 50 hedge funds were net buyers of SGMT (16 opened a new position, 34 added to an existing one), while 34 reduced or exited (18 trimmed, 16 sold completely) — a 60% buyer ratio, indicating clear institutional accumulation. 23% of total institutional value in SGMT is held by top-100 AUM funds, reflecting strong institutional quality. Net fund flow last quarter: flat (entries and exits balanced). Total institutional holders: 86.

Hedge Fund Ownership: SGMT

How many hedge funds hold SGMT — quarterly history vs. share price
Quarterly hedge fund ownership of SGMT vs. share price

Market Analysis: SGMT

Analyst Price Targets

Avg. Price Target
--

Analyst Recommendations

Stock Performance

Real-time

Company Profile: SGMT

-- --

Institutional ownership data sourced from SEC EDGAR Form 13F-HR filings.

Is It Too Late to Buy Sagimet Biosciences Inc (SGMT) Based on Hedge Fund 13F Filings?

Signal Freshness measures how much SGMT has moved relative to its sector benchmark (XLV) since the 2026 Q1 13F filing. A stock that has barely outrun its sector is still a relatively fresh entry point — the fund's thesis has not yet been priced in by the broader market.

Since Quarter End March 31, 2026 · 80d ago
SGMT
nan%
XLV
+2.1%

SGMT outperformed XLV by nan% since March 31, 2026.

Since 13F Filing Date May 15, 2026 · 35d ago
SGMT
nan%
XLV
+3.2%

Since the filing became public, SGMT outperformed XLV by nan% .

Interpretation: The stock is tracking its sector benchmark closely. The signal remains fresh and the entry point is still near the fund's implied reference. Learn more →

Smart Money Signal ?
Limited Smart Money Interest

No strong consensus or elite conviction detected among institutional holders.

9 top-rated funds 0 high-conviction
Consensus
4.3
/ 10
breadth
×
Elite
0.1
/ 10
conviction
Hedge Fund Positioning: SGMT
86 + Investors

Track Smart Money conviction in SGMT. See who's accumulating, reducing, or initiating positions.

Metric All 13F Filers (2026 Q1) Prior (2025 Q4) Change
Funds Holding 86 86 -
13F Shares 14M 15M -7.09%
Total Value $71M $88M -19.04%
New Positions 16 27 -11
Increased Positions 32 27 +5
Closed Positions 16 12 +4
Reduced Positions 18 16 +2
Total Calls 3 4 -25.0%
Total Puts 2 3 -33.33%
PUT/CALL Ratio 0.67 0.75 Bullish

Statistics: SGMT

View More

Valuation Measures Data as of: --

Market Cap --
Enterprise Value --
Trailing P/E --
Forward P/E --
PEG Ratio (5yr expected) --
Price/Sales (ttm) --
Price/Book (mrq) --
Enterprise Value/Revenue --
Enterprise Value/EBITDA --
Beta (5Y Monthly) --
Short Ratio (Days to Cover) --
Short % of Float --

Financial Highlights

Profitability
Profit Margin --
Return on Assets (ttm) --
Return on Equity (ttm) --
Income Statement & Cash Flow
Revenue (ttm) --
Net Income Avi to Common (ttm) --
Diluted EPS (ttm) --
Total Cash (mrq) --
Total Debt/Equity (mrq) --
Levered Free Cash Flow (ttm) --

Institutional Holders (2026 Q1)

86 + investors

Explore institutional interest and hedge fund ownership dynamics. Analyze portfolio weights, new positions, and conviction trends in SGMT. Verified SEC 13F-HR filings.

QUARTER:
Top 25 SGMT holders by conviction (% of portfolio weight) — 2026 Q1 · Source: SEC Form 13F
# Investor % of Portfolio Shares Mkt Value
1 Blue Owl Capital Holdings LP 0.47% 333,877 $1.7M
2 Affinity Asset Advisors, LLC 0.23% 868,020 $4.5M
3 Hhlr Advisors, LTD. 0.23% 724,800 $3.8M
4 RB Capital Management, LLC 0.11% 97,000 $507K
5 Pale Fire Capital SE 0.10% 221,875 $1.2M
6 Dumac, INC. 0.05% 71,192 $372K
7 Dynamic Technology Lab Private Ltd 0.04% 47,820 $250K
8 683 Capital Management, LLC 0.03% 126,349 $660K
9 Bridgeway Capital Management, LLC 0.03% 299,641 $1.6M
10 1492 Capital Management LLC 0.03% 15,000 $78K
11 Baker BROS. Advisors LP 0.03% 952,996 $5.0M
12 Woodline Partners LP 0.02% 1,000,943 $5.2M
13 Diametric Capital, LP 0.01% 10,043 $52K
14 Abacus Planning Group, Inc. 0.01% 18,064 $94K
15 Catalyst Funds Management Pty Ltd 0.01% 13,900 $73K
16 Landscape Capital Management, L.L.C. 0.01% 33,391 $174K
17 Hudson Bay Capital Management LP 0.01% 303,223 $1.6M
18 Renaissance Technologies LLC 0.01% 625,469 $3.3M
19 Marshall Wace, LLP 0.01% 966,253 $5.0M
20 XTX Topco Ltd 0.00% 38,099 $199K
21 MTM Investment Management, LLC 0.00% 1,870 $10K
22 China Universal Asset Management Co., Ltd. 0.00% 5,501 $29K
23 AlphaQuest LLC 0.00% 6,174 $37K
24 Jump Financial, LLC 0.00% 28,951 $151K
25 Millennium Management LLC 0.00% 862,303 $4.5M
Investor Ownership
History 		% of Portfolio Prev % Rank Conviction Avg Buy Price 13F Score™ 3Y / 7Y Sell Timing Shares Mkt Value Change Change % Source Quarter Filed

Frequently Asked Questions — Sagimet Biosciences Inc (SGMT)

What does the Smart Money Trend signal show for SGMT?

No change last quarter: The number of hedge funds holding this stock didn't change last quarter. Neither a buying nor selling signal on its own — watch the next quarter for direction.

What is the institutional breadth score for SGMT?

More buyers than sellers — 60% buying: Last quarter: 50 funds were net buyers (16 opened a brand new position + 34 added to an existing one). Only 34 were sellers (18 trimmed + 16 sold completely). A clear majority buying is a strong confirmation signal.

What is the fund quality score for SGMT holders?

Strong quality — 23% AUM from major funds: 26 of 86 holders rank in the top 100 by AUM, accounting for 23% of total institutional value held. A meaningful share of the ownership value comes from the most well-resourced institutions.

How long have hedge funds held SGMT?

Mixed — 29% long-term, 36% new: Of the 86 current holders: 25 (29%) held >2 years, 30 held 1–2 years, and 31 entered in the last year. A mixed base — the stock has long-term believers but also recent buyers who haven't been tested by a downturn yet.

Is it too late to buy Sagimet Biosciences Inc (SGMT) following the 2026 Q1 hedge fund 13F filings?

As of today, SGMT has moved nan% since the 2026 Q1 13F filing date (May 15, 2026), compared to +3.2% for the XLV sector ETF — an outperformance of nan%. Since the quarter end (March 31, 2026), SGMT has gained nan% vs +2.1% for XLV. The stock is tracking its sector benchmark closely. The signal remains fresh and the entry point is still near the fund's implied reference.

Where does this institutional ownership data come from?

All holdings data is sourced from SEC Form 13F filings, which institutional investment managers with over $100 million in assets are required to submit quarterly. Data is parsed directly from SEC EDGAR.

Disclaimer: The information on this page is for informational purposes only and does not constitute investment advice, a recommendation, or an offer to buy or sell any security. Institutional holdings data is sourced from SEC Form 13F filings and reflects positions as of the filing date. Past performance of any fund or portfolio is not indicative of future results. 13Foresight is not a registered investment adviser. Always conduct your own due diligence before making investment decisions.

Full history →